Thrivent Financial for Lutherans
FRLN

Thrivent Financial for Lutherans’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,260
Closed -$37K – 2519
2022
Q4 		$37K Buy
+5,260
New +$50.1K ﹤0.01% 2398

Other funds holding FRLN

SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Thrivent Financial for Lutherans's FRLN Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2023, closing a stake of 5,260 shares — an estimated $37K sold.

Thrivent Financial for Lutherans first reported a position in FRLN in Q4 2022 and held it in 1 quarter. The position peaked at $37K in Q4 2022. 15 funds tracked by Wall St. Rank hold FRLN as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 5,260 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2023, an estimated $37K.
  • Thrivent Financial for Lutherans first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Thrivent Financial for Lutherans's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $37K in Q4 2022.
  • 15 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.